• Explore /
  • Poster
  • / A phase II randomized therapeutic optimization trial for subjects with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial.

A phase II randomized therapeutic optimization trial for subjects with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial.

Abstract Poster

Authors

null

Sherise C. Rogers

University of Florida/UF Health Cancer Center, Gainesville, FL

Sherise C. Rogers , Shu Wang , Ryan Michael Thomas , Brian Hemendra Ramnaraign , Jesus C. Fabregas , Ilyas Sahin , Stephen Staal , Martina Cathryn Murphy , Anna Melissa Singson Murillo , Merry Jennifer Markham , Frederic J. Kaye , Coy D. Heldermon , Dennie V. Jones , Nam H. Dang , Julia Lee Close , Thomas J. George , Carmen Joseph Allegra

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04786600

DOI

10.1200/JCO.2022.40.4_suppl.TPS223

Abstract #

TPS223

Poster Bd #

N8

Abstract Disclosures

Similar Posters

First Author: Sherise C. Rogers

First Author: Jonathan Matthew Hernandez

First Author: Atsushi Ishiguro

First Author: Nicolas Huyghe